The final chapter synthesises the analysis of surrogacy, end-of-life decision-making and triage, demonstrating how each of these practices gives rise to fundamental questions at the thresholds of life and death. The issue of surrogacy gives rise to contentious debate on the tension between personal autonomy, the commodification of human beings, and the protection of children. Debates surrounding end-of-life issues demonstrate the discord between self-determination, dignity, and collective responsibility. The field of triage reveals the dilemmas of justice and democratic legitimacy in circumstances of scarcity. Across these contexts, a common concern emerges: how law should channel human desires and choices while safeguarding the vulnerable and respecting fundamental rights. In the future, new challenges such as genetic editing, artificial gestation, neuroenhancement, and the governance of artificial intelligence in medicine will intensify these tensions. The chapter argues that biolaw must remain anchored in prudence and responsibility, ensuring that freedom, justice, and human dignity are preserved in the face of accelerating biotechnological transformation.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Conclusion

  • Alessandro Ferrara

摘要

The final chapter synthesises the analysis of surrogacy, end-of-life decision-making and triage, demonstrating how each of these practices gives rise to fundamental questions at the thresholds of life and death. The issue of surrogacy gives rise to contentious debate on the tension between personal autonomy, the commodification of human beings, and the protection of children. Debates surrounding end-of-life issues demonstrate the discord between self-determination, dignity, and collective responsibility. The field of triage reveals the dilemmas of justice and democratic legitimacy in circumstances of scarcity. Across these contexts, a common concern emerges: how law should channel human desires and choices while safeguarding the vulnerable and respecting fundamental rights. In the future, new challenges such as genetic editing, artificial gestation, neuroenhancement, and the governance of artificial intelligence in medicine will intensify these tensions. The chapter argues that biolaw must remain anchored in prudence and responsibility, ensuring that freedom, justice, and human dignity are preserved in the face of accelerating biotechnological transformation.